Healthequity Inc [HQY] stock is trading at $107.71, up 3.23%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The HQY shares have gain 2.84% over the last week, with a monthly amount glided 12.57%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Healthequity Inc [NASDAQ: HQY] stock has seen the most recent analyst activity on December 04, 2024, when Mizuho initiated its Outperform rating and assigned the stock a price target of $126. Previously, Goldman started tracking the stock with Neutral rating on November 15, 2024, and set its price target to $108. On April 04, 2024, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $101 on the stock. JP Morgan reiterated its Overweight rating and increased its price target to $108 on April 02, 2024. Barclays initiated its recommendation with a Overweight and recommended $84 as its price target on January 03, 2024. Robert W. Baird upgraded its rating to Outperform for this stock on September 21, 2023, and upped its price target to $87. In a note dated October 21, 2022, Goldman upgraded an Neutral rating on this stock and boosted its target price from $64 to $77.
Healthequity Inc [HQY] stock has fluctuated between $65.01 and $107.87 over the past year. Currently, Wall Street analysts expect the stock to reach $107.5 within the next 12 months. Healthequity Inc [NASDAQ: HQY] shares were valued at $107.71 at the most recent close of the market. An investor can expect a potential drop of -0.19% based on the average HQY price forecast.
Analyzing the HQY fundamentals
Healthequity Inc [NASDAQ:HQY] reported sales of 1.15B for the trailing twelve months, which represents a growth of 20.55%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.1%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.05 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 104.94 points at the first support level, and at 102.18 for the second support level. However, for the 1st resistance point, the stock is sitting at 109.18, and for the 2nd resistance point, it is at 110.66.
Ratios To Look Out For
For context, Healthequity Inc’s Current Ratio is 3.20. Further, the Quick Ratio stands at 3.20, while the Cash Ratio is 2.08. Considering the valuation of this stock, the price to sales ratio is 8.11, the price to book ratio is 4.40 and price to earnings (TTM) ratio is 98.26.
Transactions by insiders
Recent insider trading involved Elimelech Rosner, Officer, that happened on Jan 07 ’25 when 1707.0 shares were purchased. Officer, Stephen Neeleman completed a deal on Jan 07 ’25 to buy 570.0 shares. Meanwhile, Officer James M. Lucania bought 1848.0 shares on Jan 07 ’25.
